RegulatoryOfficial

Commission lists MDCG 2026-6 on orphan IVD clinical evidence, but entry description conflicts

🇪🇺 European Commission (DG SANTE) · Tue 03 Nov 2026

DG SANTE has published MDCG 2026-6 on clinical evidence for orphan in vitro diagnostics, though the accompanying description refers to a different IVD classification guidance.

The European Commission's Directorate-General for Health and Food Safety (DG SANTE) has listed a new Medical Device Coordination Group (MDCG) document, MDCG 2026-6, dated 3 November 2026. The entry is titled as guidance on clinical evidence for orphan in vitro diagnostics (IVDs). The file is named mdcg_2026-6_en.pdf.

The source text available is minimal. It confirms only the file name, the publication date of 3 November 2026 and DG SANTE as author. It gives no detail on the content of the guidance, such as how clinical evidence expectations might apply to orphan IVDs.

The listing is also internally inconsistent. Its description cites MDCG 2020-16 rev.5, the guidance on IVD classification rules under Regulation (EU) 2017/746 (the IVDR), dated September 2026. That is a different subject from clinical evidence for orphan devices, and it is unclear whether the description was carried over in error or whether the documents are linked.

As general context, MDCG guidance documents are not legally binding, but they reflect the shared views of Member State authorities and the Commission on applying the device regulations, and notified bodies and manufacturers commonly use them in practice.

What it means for your team

  • Read the PDF of MDCG 2026-6 itself before drawing conclusions; the listing text does not describe its content.
  • Do not rely on the entry's description for IVDR classification: it cites MDCG 2020-16 rev.5 (September 2026), which should be checked separately at source.
  • Teams planning performance-evidence strategies for low-prevalence or orphan IVDs should monitor for a corrected listing from DG SANTE.

Official source: European Commission (DG SANTE) ↗

Article written by VigiEye from the official source (European Commission (DG SANTE)). AI-assisted; check the source before acting.

More Regulatory All →